259
Views
4
CrossRef citations to date
0
Altmetric
Original Research

A systematic review and meta-regression of studies eliciting willingness-to-pay per quality-adjusted life year in the general population

, , , , &
Pages 53-61 | Received 06 Nov 2020, Accepted 18 Jan 2021, Published online: 01 Feb 2021

References

  • Wilson HS. Methods for the economic evaluation of health care programmes. J Epidemiol Community Health. 1987;41(4):355–356.
  • C E P, Mushlin AI. On the (near) equivalence of cost-effectiveness and cost-benefit analyses. Int J Technol Assess Health Care. 1991;7(1):12.
  • Baker R, Chilton S, Donaldson C, et al., Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE. Health Econ Policy Law. 2011;6(4): 435.
  • Culyer A, McCabe C, Briggs A, et al. Searching for a threshold, not setting one: the role of the national institute for health and clinical excellence. J Health Serv Res Policy. 2007;12(1):56–58.
  • Woods B, Revill P, Sculpher M, et al. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016;19(8):929–935.
  • Gyrd-Hansen D. Willingness to pay for a QALY. Pharmacoeconomics. 2005;23(5):423–432.
  • Vallejo-Torres L, García-Lorenzo B, Castilla I, et al., On the estimation of the cost-effectiveness threshold: why, what, how? Value Health. 2016;19(5): 558–566.
  • Mason H, Baker R, Donaldson C. Willingness to pay for a QALY: past, present and future. Expert Rev Pharmacoecon Outcomes Res. 2008;8(6):575–582.
  • Ryen L, Svensson M. The willingness to pay for a quality adjusted life year: a review of the empirical literature. Health Econ. 2015;24(10):1289–1301.
  • Nimdet K, Chaiyakunapruk N, Vichansavakul K, et al., A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold? PloS One. 2015;10(4): e0122760.
  • Van Houtven G, Powers J, Jessup A, et al. Valuing avoided morbidity using meta‐regression analysis: what can health status measures and QALYs tell us about WTP? Health Econ. 2006;15(8):775–795.
  • Nelson JP, Kennedy PE. The use (and abuse) of meta-analysis in environmental and natural resource economics: an assessment. Environ Resour Econ. 2009;42(3):345–377.
  • Van Houtven GL, Pattanayak SK, Usmani F, et al. What are households willing to pay for improved water access? Results from a meta-analysis. Ecol Econ. 2017;136:126–135.
  • Bellavance F, Dionne G, Lebeau M. The value of a statistical life: a meta-analysis with a mixed effects regression model. J Health Econ. 2009;28(2):444–464.
  • Horváthová E. Does environmental performance affect financial performance? A meta-analysis. Ecol Econ. 2010;70(1):52–59.
  • PROSPERO [Internet]. York: XXX. [cited 2020 Aug].  Available from: https://www.crd.york.ac.uk/PROSPERO/
  • Van Houtven G. Methods for the meta-analysis of willingness-to-pay data: an overview. PharmacoEconomics. 2008;26(11):901–910.
  • J A W, Lancsar E, Rixon K, et al. A systematic review of stated preference studies reporting public preferences for healthcare priority setting. Patient. 2014;7(4):365–386.
  • World Bank Open Data [Internet]. Washington (DC): World Bank.  [cited 2020 Sep] Available from: https://data.worldbank.org.cn/.
  • OECD data [Internet]. Paris: The OECD. [cited 2020 Sep]. Available from: https://data.oecd.org/
  • Quandl [Internet]. Toronto: Quandl. [cited 2020 Sep] Available from: https://www.quandl.com/
  • IndexMundi [Internet]. [cited 2020 Sep]. Available from: https://www.indexmundi.com/
  • US Inflation Calculator [Internet]. [cited 2020 Sep]. Available from: https://www.usinflationcalculator.com
  • Borenstein M, Hedges L, Higgins J, et al. Comprehensive meta analysis version 3. Englewood, NJ: Biostat; 2013.
  • C S B, D C H, Mosteller F, et al. A random‐effects regression model for meta‐analysis. Stat Med. 1995;14(4):395–411.
  • C R F, A M G, M R B, et al. Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems. Proceedings of the AMIA annual fall symposium. American Medical Informatics Association. 1997: 223. Nashville, TN, USA.
  • Gyrd‐Hansen D. Willingness to pay for a QALY. Health Econ. 2003;12(12):1049–1060.
  • M M B, O’Malley K, Suarez-Almazor ME. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis. Med Decis Mak. 2005;25(6):655–666.
  • Bobinac A, Van Exel NJA, F F H R, et al. Willingness to pay for a quality-adjusted life-year: the individual perspective. Value Health. 2010;13(8):1046–1055.
  • J L P-P, Loomes G, Brey R. Trying to estimate a monetary value for the QALY. J Health Econ. 2009;28(3):553–562.
  • Shiroiwa T, Y K S, Fukuda T, et al. International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422–437.
  • Von Stackelberg K, Hammitt J. Use of contingent valuation to elicit willingness-to-pay for the benefits of developmental health risk reductions. Environ Resour Econ. 2009;43(1):45–61.
  • Donaldson C, Robinson A, Persson U, et al. European value of a quality adjusted life year. Government Report. 2011. Available from: http://research.ncl.ac.uk/eurovaq/EuroVaQ_Final_Publishable_Report_and_Appendices.pdf.
  • Bobinac A, van Exel J, F F H R, et al. The value of a QALY: individual willingness to pay for health gains under risk. Pharmacoeconomics. 2014;32(1):75–86.
  • Bobinac A, van Exel NJA, F F H R, et al. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation. J Health Econ. 2012;31(1):158–168.
  • Bobinac A, Van Exel NJA, F F H R, et al. Valuing QALY gains by applying a societal perspective. Health Econ. 2013;22(10):1272–1281.
  • Gyrd‐Hansen D, Kjær T. Disentangling WTP per QALY data: different analytical approaches, different answers. Health Econ. 2012;21(3):222–237.
  • Nimdet K, Ngorsuraches S. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand. BMJ Open. 2015;5(10):e008123.
  • Pennington M, Baker R, Brouwer W, et al. Comparing WTP values of different types of QALY gain elicited from the general public. Health Econ. 2015;24(3):280–293.
  • A A S, Y W L, G N C, et al. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia. ClinicoEconomics and outcomes research: CEOR. 2014;6: 473.
  • Shiroiwa T, Igarashi A, Fukuda T, et al. WTP for a QALY and health states: more money for severer health states? Cost Eff Resour Allocation. 2013;11(1):22.
  • Thavorncharoensap M, Teerawattananon Y, Natanant S, et al. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? ClinicoEconomics and outcomes research: CEOR. 2013;5: 29.
  • Tilling C, Krol M, Attema AE, et al. Exploring a new method for deriving the monetary value of a QALY. Eur J Health Econ. 2016;17(7):801–809.
  • van de Wetering L, van Exel J, Bobinac A, et al. Valuing QALYs in relation to equity considerations using a discrete choice experiment. Pharmacoeconomics. 2015;33(12):1289–1300.
  • F L Z, Yue M, Yang H, et al. Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making? results from a study in patients with chronic prostatitis. Med Care. 2011;49(3):267–272.
  • Robinson A, Gyrd-Hansen D, Bacon P, et al. Estimating a WTP-based value of a QALY: the ‘chained’approach. Soc Sci Med. 2013;92:92–104.
  • Ahlert M, Breyer F, Schwettmann L What you ask is what you get: willingness-to-pay for a QALY in Germany. CESIFO WORKING PAPER. 2013. Available from: https:www.CESifo-group.org/wp.
  • Ahlert M, Breyer F, Schwettmann L. How you ask is what you get: framing effects in willingness-to-pay for a QALY. Soc Sci Med. 2016;150:40–48.
  • Attema AE, Krol M, van Exel J, et al. New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year. Eur J Health Econ. 2018;19(2):277–291.
  • K B L, Ghahramani S, Moradi N, et al. Willingness-to-pay for one quality-adjusted life-year: a population-based study from Iran. Appl Health Econ Health Policy. 2018;16(6):837–846.
  • Y W L, A A S, G N C, et al. Determination of cost-effectiveness threshold for health care interventions in Malaysia. Value Health. 2017;20(8):1131–1138.
  • Moradi N, Rashidian A, Nosratnejad S, et al. Willingness to pay for one quality-adjusted life year in Iran. Cost Eff Resour Allocation. 2019;17(1):4.
  • Olofsson S, U G G, Hultkrantz L, et al. Value of a QALY and VSI estimated with the chained approach. Eur J Health Econ. 2019;20(7):1063–1077.
  • Soeteman L, van Exel J, Bobinac A. The impact of the design of payment scales on the willingness to pay for health gains. Eur J Health Econ. 2017;18(6):743–760.
  • H J S, Lee EK. Evaluation of willingness to pay per quality-adjusted life year for a cure: a contingent valuation method using a scenario-based survey. Medicine (Baltimore). 2018;97(38): e12453.
  • Sund B, Svensson M. Estimating a constant WTP for a QALY—a mission impossible? Eur J Health Econ. 2018;19(6):871–880.
  • Olofsson S, U G G, Hultkrantz L, et al. Measuring the end-of-life premium in cancer using individual ex ante willingness to pay. Eur J Health Econ. 2018;19(6):807–820.
  • Pennington M, Gomes M, Donaldson C. Handling protest responses in contingent valuation surveys. Med Decis Mak. 2017;37(6):623–634.
  • Kahneman D, Knetsch JL. Valuing public goods: the purchase of moral satisfaction. J Environ Econ Manage. 1992;22(1):57–70.
  • R G E, G L P, W D S. et al. A comparison of hypothetical phone and mail contingent valuation responses for green-pricing electricity programs. Land Econ. 2000; 54–67.
  • S H X T, C R V, Nair R. Critical review of willingness to pay for clinical oral health interventions. J Dent. 2017;64:1–12.
  • Dolan P, Shaw R, Tsuchiya A, et al. QALY maximisation and people’s preferences: a methodological review of the literature. Health Econ. 2005;14(2):197–208.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.